CD157 enhances malignant pleural mesothelioma aggressiveness and predicts poor clinical outcome
ONCOTARGET
Authors: Ortolan, Erika; Giacomino, Alice; Martinetto, Francesca; Morone, Simona; Lo Buono, Nicola; Ferrero, Enza; Scagliotti, Giorgio; Novello, Silvia; Orecchia, Sara; Ruffini, Enrico; Rapa, Ida; Righi, Luisella; Volante, Marco; Funaro, Ada
Abstract
Malignant mesothelioma is a deadly tumor whose diagnosis and treatment remain very challenging. There is an urgent need to advance our understanding of mesothelioma biology and to identify new molecular markers for improving management of patients. CD157 is a membrane glycoprotein linked to ovarian cancer progression and mesenchymal differentiation. The common embryonic origin of ovarian epithelial cells and mesothelial cells and the evident similarities between ovarian and mesothelial cancer prompted us to investigate the biological role and clinical significance of CD157 in malignant pleural mesothelioma (MPM). CD157 mRNA and protein were detected in four of nine MPM cell lines of diverse histotype and in 85.2% of MPM surgical tissue samples (32/37 epithelioid; 37/44 biphasic). CD157 expression correlated with clinical aggressiveness in biphasic MPM. Indeed, high CD157 was a negative prognostic factor and an independent predictor of poor survival for patients with biphasic MPM by multivariate survival analysis (HR = 2.433, 95% CI 1.120-5.284; p = 0.025). In mesothelioma cell lines, CD157 gain (in CD157-negative cells) or knockdown (in CD157-positive cells) affected cell growth, migration, invasion and tumorigenicity, most notably in biphasic MPM cell lines. In these cells, CD157 expression was associated with increased activation of the mTOR signaling pathway, resulting in decreased platinum sensitivity. Moreover, a trend towards reduced survival was observed in patients with biphasic MPM receiving postoperative platinum-based chemotherapy. These findings indicate that CD157 is implicated in multiple aspects of MPM progression and suggest that CD157 expression could be used to stratify patients into different prognostic groups or to select patients that might benefit from particular chemotherapeutic approach.
Fabrication of Barium Stannate Tatanate Ceramics via Combustion Technique
SMART MATERIALS
Authors: Wattanawikkam, C.; Bongkarn, T.
Abstract
The effect of firing temperatures on phase formation and microstructure of barium stannate titanate [Ba(Sn0.1Ti0.9)O-3-, BST10] ceramics were investigated. BST1 was synthesized via a combustion method, at various calcination and sintering temperatures. It was found that, a single perovskite of BST10 powders was obtained with a calcinations temperature of 1200 degrees C. The percent of the perovskite phase and the lattice parameter were increased with increasing calcination temperatures. The average particle size was increased front 0.48 to 1.69 mu m by increasing the calcined temperature from 600 to 1200 degrees C. The average grain sizes were increased from 0.99 to 17.77 mu m by increasing the sintering temperature from 1250 to 1450 degrees C. The maximum density and dielectric constant were observed in sintered samples at 1350 degrees C.